Detection and Quantification of New Designer Drugs in Human Blood: Part 1 – Synthetic Cannabinoids

By Ammann Julia   McLaren Jenna M.   Gerostamoulos Dimitri   Beyer Jochen  

Journal of Analytical Toxicology, Vol. 36, Iss. 6, 2012-07 ,pp. : 372-380

Oxford University Press

Access to resources Recommend Favorite

Piperazine-Derived Designer Drug 1-(3-Chlorophenyl)piperazine (mCPP): GC-MS Studies on its Metabolism and its Toxicological Detection in Rat Urine Including Analytical Differentiation from its Precursor Drugs Trazodone and Nefazodone

By Staack Roland F.   Maurer Hans H.  

Journal of Analytical Toxicology, Vol. 27, Iss. 8, 2003-11 ,pp. : 560-568

Oxford University Press

Access to resources Recommend Favorite

A New, Rapid Gas Chromatography Method for the Detection of Basic Drugs in Postmortem Blood Using a Nitrogen Phosphorus Detector. Part II. Quantitative Analysis

By Kopjak Ladislav  

Journal of Analytical Toxicology, Vol. 3, Iss. 4, 1979-07 ,pp. : 155-157

Oxford University Press

Access to resources Recommend Favorite

Two Fatal Intoxications with the New Designer Drug Methedrone (4-Methoxymethcathinone)

By Wikström Maria  

Journal of Analytical Toxicology, Vol. 34, Iss. 9, 2010-11 ,pp. : 594-598

Oxford University Press

Access to resources Recommend Favorite

MEMBRANE BIOREACTORS - A DESIGNER'S PERSPECTIVE

By Crawford George   Thompson Doug   Lozier Jim   Daigger Glen   Fleischer Ed  

Proceedings of the Water Environment Federation, Vol. 2000, Iss. 9, 2000-01 ,pp. : 311-319

Water Environment Federation

Access to resources Recommend Favorite